Are there differences in the treatment strategies and outcomes between high-risk multiple myeloma patients and those with low-risk disease and without comorbities?.
Hematology Meeting Reports,
[S. l.], v. 2, n. 7, 2009. DOI:
10.4081/hmr.v2i7.407. DisponÃvel em:
https://journals.pagepress.org/hmr/article/view/407. Acesso em: 18 jul. 2025.